Candel Therapeutics stock was listed on the Nasdaq exchange on August 18, 2026.
1 report, 1 independent
Updated Aug 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Candel Therapeutics stock was listed on the Nasdaq exchange on August 18, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Candel Therapeutics
company in Auburndale, United States
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
Related events
- HCW Biologics announced it is listed on the Nasdaq stock exchange.
- Decoy Therapeutics was listed on the Nasdaq stock exchange on September 22, 2026.
- Cyclerion Therapeutics, Inc. and Kiora Pharmaceuticals are newly listed on the NASDAQ stock exchange.
- Cardiol Therapeutics Inc. is listed on Nasdaq and is developing therapy for an FDA-approved indication.
- Alvotech utilized Nasdaq for its public stock listing and is currently undergoing comprehensive review by the FDA for biosimilar applications.